SAP18 and T-cell leukemia: Here, we identified a unique HDACi that possessed a potent anti-T cell leukemia activity by direct binding to and stabilization of SAP18, leading to downregulation of SIRT3 transcription through activation of the SAP18/SIN3 suppressor complex, resulting in apoptotic cell death.